The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multicenter randomized phase II study of weekly docetaxel alone versus weekly docetaxel plus oxaliplatin as a second-line chemotherapy in patients with advanced gastric cancer: Preliminary response and safety results.
Jin Young Kim
No relevant relationships to disclose
Young Rok Do
No relevant relationships to disclose
Keon Uk Park
No relevant relationships to disclose
Hun-Mo Ryoo
No relevant relationships to disclose
Sung Hwa Bae
No relevant relationships to disclose
Yee Soo Chae
No relevant relationships to disclose
Min Kyoung Kim
No relevant relationships to disclose
Kyung Hee Lee
No relevant relationships to disclose
Sun Ah Lee
No relevant relationships to disclose
Jong Gwang Kim
No relevant relationships to disclose
Hong-Suk Song
No relevant relationships to disclose